US2013209360A1PendingUtilityA1
Compositions and Methods for Imaging
Est. expiryAug 23, 2030(~4.1 yrs left)· nominal 20-yr term from priority
A61P 35/00G01N 33/84C07C 59/84C07C 255/57A61K 49/101C07C 57/30A61K 2123/00C07C 205/57C07C 59/88A61P 29/00C07D 213/30C07B 59/00C07B 2200/05A61K 51/0402
44
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present disclosure provides compositions for in vivo imaging of hydrogen peroxide; and methods for detecting hydrogen peroxide in vivo. The compositions and methods find use in various diagnostic applications, which are also provided.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A compound of the formula:
wherein Z is a aryl or a heteroaryl group, that includes one or more isotopically labeled atoms capable of being hyperpolarized by dynamic nuclear polarization.
2 . The compound of claim 1 , wherein Z is a pyridyl group that may be unsubstituted or substituted with one or more R 1 groups, wherein each R 1 is independently selected from hydrogen, deuterium, a halogen, cyano, nitro, a trihalomethyl, an alkoxy, an aryloxy, an alkyl, an aryl, a heterocycle, a thiol, a thioether, an acyl, and hydroxyl.
3 . The compound of claim 1 , Z is a phenyl group that is unsubstituted or substituted with one or more R 1 groups.
4 . The compound of claim 3 , wherein the compound is of the formula:
wherein R 1 is one or more groups, each R 1 independently selected from hydrogen, deuterium, a halogen, cyano, nitro, a trihalomethyl, an alkoxy, an aryloxy, an alkyl, an aryl, a heterocycle, a thiol, a thioether, an acyl, and hydroxyl,
wherein at least one atom is labeled with an isotope suitable for hyperpolarization.
5 . The compound of claim 4 , wherein the compound comprises at least one 13 C atom as shown in one of the following structures:
wherein R 2 is one or more groups, each R 2 independently selected from hydrogen, deuterium, a halogen, cyano, nitro, a trihalomethyl, an alkoxy, an aryloxy, an alkyl, an aryl, a heterocycle, a thiol, a thioether, an acyl, and hydroxyl.
6 . The compound of claim 4 , wherein the compound is of the formula:
wherein R 11 , R 12 , R 13 , R 14 and R 15 are each independently selected from hydrogen, deuterium, a halogen, cyano, nitro, a trihalomethyl, an alkoxy, an aryloxy, an alkyl, an aryl, a heterocycle, a thiol, a thioether, an acyl, and hydroxyl.
7 . The compound of claim 4 , wherein the compound is of one of the following formulas:
wherein R 21 , R 22 , R 23 , R 31 , R 32 and R 33 are each independently selected from hydrogen, deuterium, a halogen, cyano, nitro, a trihalomethyl, an alkoxy, an aryloxy, an alkyl, an aryl, a heterocycle, a thiol, a thioether, an acyl, and hydroxyl
8 . The compound of claim 4 , wherein the compound is of one of the following structures:
9 . The compound of claim 2 , wherein the compound is a compound of one of the following formulas:
wherein R 1 is one or more groups, each R 1 independently selected from hydrogen, deuterium, a halogen, cyano, nitro, a trihalomethyl, an alkoxy, an aryloxy, an alkyl, an aryl, a heterocycle, a thiol, a thioether, an acyl, and hydroxyl; and
wherein at least one atom is labeled with an isotope suitable for hyperpolarization by DNP.
10 . The compound of claim 1 , wherein the at least one isotopically labeled atom is selected from 13 C and 15 N.
11 . A composition comprising:
a) a compound of claim 1 ; and b) a buffer.
12 . A pharmaceutical composition comprising:
a) a compound of claim 1 ; and b) a pharmaceutically acceptable excipient.
13 . A method of detecting hydrogen peroxide in a cell, tissue, or organ, or extracellularly in an individual, the method comprising:
a) administering to the individual a compound of claim 1 , or a composition of claim 11 or claim 12 ; and b) detecting a signal produced by the compound upon reaction with hydrogen peroxide.
14 . The method of claim 13 , wherein the compound is hyperpolarized, and wherein said detecting is by hyperpolarized magnetic resonance imaging.
15 . The method of claim 13 , wherein hydrogen peroxide is selectively detected in a range of from about 2.5 μM to about 250 μM.
16 . The method of claim 13 , wherein the individual is a human.
17 . The method of claim 13 , wherein said detecting is performed at a first time and at a second time that is later than the first time.
18 . The method of claim 17 , wherein the first time is before administration of a therapeutic agent to the individual, and the second time is after administration of a therapeutic agent to the individual.
19 . The method of claim 13 , wherein said detecting provides for diagnosis of a disease or disorder characterized at least in part by an excess of hydrogen peroxide.
20 . The method of claim 13 , wherein said detecting provides for a determination of the efficacy of a therapeutic agent or other treatment for a disease or disorder characterized at least in part by an excess of hydrogen peroxide.
21 . The method of claim 20 , wherein the disease or disorder characterized at least in part by an excess of hydrogen peroxide is cancer, inflammation, aging, cardiovascular disease, diabetes, neurodegenerative disease, or stroke.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.